Search clinical trials for: Pyrotinib plus trastuzumab and docetaxel and carboplatin
Total 9099 results
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Fudan UniversityCompleted
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Cancer Trials IrelandCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaboratorsUnknownColorectal CancerChina
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminated
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Diseases | Neoplasm, BreastChina
-
Peking University Cancer Hospital & InstituteNot yet recruiting
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Genentech, Inc.Completed
-
Shandong Cancer Hospital and InstituteUnknownBreast Cancer | HER2-positive Breast CancerChina
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
University of MiamiAventis PharmaceuticalsCompletedBreast CancerUnited States
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Anhui Provincial Cancer Hospital; Affiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and other collaboratorsRecruiting
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina
-
Wuhan Union Hospital, ChinaRecruitingBreast Cancer | NeoadjuvantChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
Huihua XiongNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Zhejiang Cancer HospitalRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Gastric CancerChina
-
Henan Cancer HospitalUnknown
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los AngelesCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
Shengjing HospitalNot yet recruiting
-
Wang OuchenRecruiting
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
Fudan UniversityRecruiting
-
Shanghai Changzheng HospitalUnknown
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
Shandong Cancer Hospital and InstituteUnknownMetastatic Breast Cancer | HER2-positive Breast Cancer
-
Fujian Medical University Union HospitalRecruiting
-
Case Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina